Clinical Trial

Higher vs. Lower Dose Heparin for PCI

Study acronym: HD-PCI
Recruiting
View on ClinicalTrials.gov →
Summary
HD PCI is a multicenter, randomized, registry-based, cluster crossover design trial of higher dose versus lower dose heparin in patients undergoing elective percutaneous coronary intervention (PCI).
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2019-08-06; most recent amendment 2025-07-28.
Status change: Not Yet Recruiting → Recruiting 2022-09-19
Trial Details
NCT Number NCT04049591
Lead Sponsor Population Health Research Institute
Conditions Cardiovascular Diseases, Percutaneous Coronary Intervention
Enrollment 16,000 participants
Start Date 2022-03-02
Primary Completion 2024-10-08 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2025-07-31